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Immune tolerance against enteric commensal bac-
teria is important for preventing intestinal inflamma-
tion. Deletion of phosphoinositide-dependent pro-
tein kinase 1 (Pdk1) in T cells via Cd4-Cre induced
chronic inflammation of the intestine despite the
importance of PDK1 in T cell activation. Analysis of
colonic intraepithelial lymphocytes of PDK1-defi-
cient mice revealed markedly increased CD8a+ T cell
receptor (TCR)gd+ T cells, including an interleukin-17
(IL-17)-expressing population. TCRgd+ T cells were
responsible for the inflammatory colitis as shown
by the fact that deletion of Tcrd abolished sponta-
neous colitis in the PDK1-deficient mice. This dysre-
gulation of intestinal TCRgd+ T cells was attributable
to a reduction in the number and functional capacity
of PDK1-deficient T regulatory (Treg) cells. Adoptive
transfer of wild-type Treg cells abrogated the spon-
taneous activation and proliferation of intestinal
TCRgd+ T cells observed in PDK1-deficient mice
and prevented the development of colitis. Therefore,
suppression of intestinal TCRgd+ T cells by Treg cells
maintains enteric immune tolerance.
INTRODUCTION
Colitis, including ulcerative colitis and Crohn’s disease, are
chronic, immunologically mediated disorders that lead to a range
of symptoms including abdominal pain, severe diarrhea, rectal
bleeding, and wasting (Xavier and Podolsky, 2007). Studies
have shown that commensal bacteria in the intestine are the
main trigger of the inflammatory response, and treatment with
antibiotics reduces intestinal inflammation in humans and exper-
imental animals (Elson, 2000; Videla et al., 1994). Therefore,
immune tolerance toward normal commensal bacteria is critical
for maintaining enteric immune homeostasis. In human diseases
such as Crohn’s disease and ulcerative colitis, it has been
reported that activated T cell receptor (TCR)gd+ T cells accumu-Ilate in the inflamed region (McVay et al., 1997; Yeung et al.,
2000). However, the role of TCRgd+ T cells in inflammatory bowel
disease and, in particular, whether they are involved in induction
or regulation of inflammation, has remained a controversial issue
(Nanno et al., 2007).
TCRgd+ T cells were discovered nearly 25 years ago, yet even
now their biological role remains to be fully understood (Hayday
et al., 1985; Nanno et al., 2007). A portion of the TCRgd+ T cell
population develops in the thymus, similar to TCRab+ T cells
(Nanno et al., 2007). However, unlike TCRab+ T cells, TCRgd+
T cells can also develop outside of the thymus as evidenced
by the TCRgd+ T cell population in thymectomized mice and in
athymic nude mice (Bandeira et al., 1990; Nanno et al., 2007;
Saito et al., 1998). Serological studies indicate that TCRgd+
T cells are more abundant in the intraepithelial lymphocyte
(IEL) compartment (up to 30%) than peripheral blood (Nanno
et al., 2007). In the IEL compartment, most of the TCRgd+
T cells are CD8a positive (Hayday and Tigelaar, 2003; Nanno
et al., 2007). CD8a+ IEL are proposed to have an extrathymic
origin, being the progeny of bone-marrow-derived stem cells
that develop in novel lymphoid sites termed cryptopatches in
the small and large intestinal mucosa (Saito et al., 1998).
In experimental colitis models that are induced by chemical-
mediated damage such as dextran sulfate sodium (DSS) or
2,4,6-trinitrobenzene sulfonic acid (TNBS) treatment, Tcrd/
mice display more severe colitis than wild-type control mice
(Chen et al., 2002; Inagaki-Ohara et al., 2004). Transferring of
self-I-Ab-reactive T cell clones into mice induces transient
graft-versus-host disease (GVHD) and these mice subsequently
recover and become resistant to the GVHD. However, this resis-
tance does not occur in Tcrd/ mice (Shiohara et al., 1996).
Based on these data, it has been suggested that TCRgd+
T cells are important for immunoregulation. However, interest-
ingly, in the spontaneous colitis that develops in Tcra/ mice,
TCRgd+ T cells are involved in the induction of colitis (Nanno
et al., 2008). In addition, it was recently shown that TCRgd+
T cells contribute to the induction of experimental autoimmune
encephalomyelitis (EAE) and collagen-induced arthritis (Ito
et al., 2009; Sutton et al., 2009). In the EAE model, TCRgd+
T cells work as a fast-acting T cell population that produces
the inflammatory cytokine IL-17 (Sutton et al., 2009). Moreover,
during blood transfusion, it is known that the severity of GVHDmmunity 33, 791–803, November 24, 2010 ª2010 Elsevier Inc. 791
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correlated with Treg cell abundance in donor blood (Pabst et al.,
2007). Finally, bone marrow transplantation-mediated GVHD is
exacerbated by TCRgd+ T cells (Maeda et al., 2005). Taken
together, these data reveal conflicting roles for TCRgd+ T cells
as both immune regulators and mediators of inflammation.
Treg cells have been shown to play an important role in intes-
tinal homeostasis in models of experimental colitis (Saurer and
Mueller, 2009). Moreover, the severity of colitis in humans has
been shown to be inversely correlated with the frequency of
peripheral Treg cells (Takahashi et al., 2006). In the PI3KdD910A
mouse strain and ‘‘r1DT/r2n’’ mouse strain that lacks both
Pik3r1 (encoding p85a, p55a, and p50a) and Pik3r2 (encoding
p85b) in T cells, both Treg cell development andTreg cell function
are diminished, which results in induction of inflammation,
includingcolitis (FrumanandBismuth,2009;Oaket al., 2006;Pat-
ton et al., 2006). Also, CD28-deficient mouse strains show dimin-
ished production of IL-10, whereas strong activation of CD28
signaling by superagonistic CD28 antibody enhances production
of IL-10 from Treg cells (Beyersdorf et al., 2005; Toto et al., 2000).
In this study, we show that deletion of the phosphoinositide-
dependent protein kinase 1 (Pdk1) gene by Cd4-Cre (T cell-
specific deletion) impairs Treg cell activation as well as CD4+
T cell activation. Unexpectedly, the TCRgd+ T cell population
was dramatically increased in the colonic IEL population of the
Pdk1 gene-deleted mice. We found that TCRgd+ T cells are
constitutively activated by commensal bacteria and that this
activation-mediated expansion of TCRgd+ T cells is suppressed
by wild-type Treg cells. In vitro, Treg cells directly suppressed
TCRgd+ T cells through IL-10. Therefore, our data show that
suppression of intestinal TCRgd+ T cells by Treg cells helps
maintain normal intestinal homeostasis.
RESULTS
T Cell-Specific Deletion of the Pdk1 Gene by Cd4-Cre
Induces Spontaneous Colitis
We have recently shown via the T cell-specific deletion of the
Pdk1 gene by Cd4-Cre (Tg(Cd4-Cre)1Cwi) that PDK1 plays an
essential role in CD4+ T cell activation, by transducing signals
from the CD28 coreceptor leading to activation of NF-kB (Park
et al., 2009). Therefore it was highly surprising to find that the
T cell-specific deletion of the Pdk1 gene by Cd4-Cre induced
spontaneous colitis (Figure 1A and Figure S1 available online)
even though CD4+ T cell activation was dramatically reduced
(Park et al., 2009). Pdk1 gene-deleted mice (Pdk1flox/flox; Cd4-
Cre) display a high incidence of rectal prolapse, unlike littermate
controls in the same breeding cage (Figure 1B). This surprising
observation suggests that spontaneous colitis is not caused by
activation of conventional T cells and is not due to external
factors such as intestinal flora. The prolapsed mice displayed
severe inflammation in the intestine (Figure 1A) and young
mice also showed abundant lymphocytic infiltration in both
small and large intestine (data not shown). Interestingly, serum
IL-12p40 in Pdk1flox/flox; Cd4-Cre mice was significantly higher
(Figure 1C), similar to observations in Crohn’s disease (Sartor,
2006). IL-12p40 was also significantly increased throughout
the colon of Pdk1flox/flox; Cd4-Cre mice (Figure 1D). IL-12p40
mRNA in the Pdk1flox/flox;Cd4-Cre colon was similarly increased,792 Immunity 33, 791–803, November 24, 2010 ª2010 Elsevier Inc.as were mRNA amounts of the proinflammatory cytokines
IL-17A, IL-23p19, and TNF-a (Figures 1E–1H). However, expres-
sion of IL-4, IFN-g, IL-12p35, and TGF-b were not significantly
increased in the colon (Figures 1I–1L). Numerous recent reports
have shown that IL-17A expression is linked with induction of
inflammation (Bettelli et al., 2006; McGeachy et al., 2009). More-
over, the cytokine IL-23, which is a heterodimer of IL-12p40 and
IL-23p19, is important for expansion and maintenance of IL-17-
expressing T cells (Ahern et al., 2008; Awasthi and Kuchroo,
2009; Mangan et al., 2006; McGeachy et al., 2009; Veldhoen
and Stockinger, 2006). Therefore, we hypothesized that IL-17-
expressing T cells might be playing an important role in intestinal
inflammation in Pdk1flox/flox; Cd4-Cre mice.
TCRgd+ T Cell Population Is Dramatically Increased
in Spontaneous Colitis
IL-17 is primarily expressed by Th17 cells, a recently character-
ized subset of CD4+ T cells (Awasthi and Kuchroo, 2009).
Because conventional T cells cannot be activated without PDK1
(Park et al., 2009), we wanted to determine which cell population
was responsible for the increased amounts of IL-17A mRNA in
the intestine of the Pdk1flox/flox; Cd4-Cre mice. We analyzed
the T cell population in the intestinal epithelial cells (IEL) and
lamina propria (LP) compartments via flow cytometry (Figure 2A).
Interestingly, neither the number of conventional TCRb+ T cells,
nor the CD19+ B cell population, which has been implicated in
spontaneous colitis through production of autoantibody (Bhan
et al., 2000; Mizoguchi et al., 1996; Targan and Karp, 2005),
were significantly affected in either the IEL or LP cells (Figure 2A).
Instead, the TCRgd+ T cell population, in particular the CD8a+
TCRgd+ T cell population, was dramatically increased in the IEL,
but not LP, of Pdk1flox/flox; Cd4-Cre mice (Figures 2A and 2B).
This was not due to PDK1 changes in TCRgd+ T cells, because
the Pdk1 gene was not deleted in these cells (Figure S2).
Interestingly, surface expression of CD69, an early T cell acti-
vation marker, was higher in TCRgd+ T cells from the IEL
compartment than in TCRgd+ T cells in the LP (Figure 2C). In
addition, the CD69-positive IEL TCRgd+ T cells of Pdk1flox/flox;
Cd4-Cre mice were increased relative to wild-type control
mice. These results indicate that TCRgd+ T cells in the colonic
IEL compartment are frequently activated and that IEL TCRgd+
T cells are more activated in Pdk1flox/flox; Cd4-Cre mice. The
number of TCRgd+ T cell was increased only slightly in the
thymus and peripheral lymph nodes (Figure S3), suggesting
that the dramatic increase of intestinal TCRgd+ T cells in the
Pdk1flox/flox;Cd4-Cremice was probably due to enhanced prolif-
eration. Interestingly, in the lymph node, TCRgd+ T cells from the
Pdk1flox/flox;Cd4-Cremice expressedmore IL-17A than IFN-g, in
contrast toPdk1+/flox;Cd4-Cremice (Figure 2D). These data indi-
cate that in the Pdk1flox/flox; Cd4-Cremice, the balance between
IL-17A- and IFN-g-expressing TCRgd+ T cells was altered. More
interestingly, IL-17A-expressing TCRgd+ T cells were increased
in the colonic IEL of Pdk1flox/flox; Cd4-Cre mice (Figure 2E). Vg4
TCRgd+ T cells usually represent a small proportion of the
colonic IEL (Pereira et al., 1997). However, consistent with the
observed elevation in TCRgd+ T cell IL-17A production (Fig-
ure 2E) and IEL IL-17A (Figure 1G), we found that the Vg4
TCRgd+ T cell population was increased in the Pdk1flox/flox;
Cd4-Cre mice (Figure 2F).
Figure 1. Pdk1 Gene Deletion by Cd4-Cre Induces Spontaneous Colitis
(A) Photograph of the colon of a rectally prolapsed Pdk1flox/flox; Cd4-Cre mouse (flox/flox) and its littermate control Pdk1+/flox; Cd4-Cre mouse (+/flox) (original
magnification 1003).
(B) Incidence of rectal prolapse (n = 15 mice per each group).
(C) ELISA analysis of serum IL-12p40 (samples pooled, n = 8–9 mice per each group).
(D) ELISA analysis for IL-12p40 level of ileum and colon explant cultures.
(E–H) Relative mRNA of IL-12p40 (E), IL-23p19 (F), IL-17A (G), TNF-a (H), IL-4 (I), IFN-g (J), IL-12p35 (K), and TGF-b (L) normalized to b-actin in colon (n = 3–4mice
per each group).
Error bars (C–L), SD of triplicate samples. *p < 0.05, **p < 0.01.
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of Spontaneous Colitis
Based on the results presented above, the increase in the
TCRgd+ T cell population in colonic IELs may lead to sponta-
neous colitis. However, the data from several experimental
colitis models, e.g., tissue injury induced by DSS or TNBS treat-
ment, suggest that TCRgd+ T cells are protective in such models
(Chen et al., 2002; Inagaki-Ohara et al., 2004). In contrast,
TCRgd+ T cells are dramatically increased in Tcra/ mice that
develop spontaneous colitis (Mizoguchi et al., 1996). Further-
more, in human colitis such as Crohn’s disease and ulcerative
colitis, activated TCRgd+ T cells are increased in the colitic
area (McVay et al., 1997; Yeung et al., 2000). Unlike injury-medi-
ated colitis, TCRgd+ T cells are involved in development of the
spontaneous colitis in Tcra/ mice (Mizoguchi et al., 1996;INanno et al., 2008) and colitis induced by transfer of bone
marrow cells from Tcrb/ mice into Cd33 transgenic mice
(Simpson et al., 1997). Thus, it has been controversial whether
TCRgd+ cells participate in the development or prevention of
colitis, even though division of function by TCR variants has
been suggested (Bonneville, 2006). We therefore directly tested
the effect of removing the TCRgd+ T cell population from the
Pdk1flox/flox; Cd4-Cre mice by crossing these mice with the
Tcrd/ mice. Remarkably, the double-deficient mice (Tcrd/,
Pdk1flox/flox; Cd4-Cre) did not show any rectal prolapse (Fig-
ures 3A and 3B) and showed dramatically reduced signs of
colitis (Figure 3C), even though Tcrd+/, Pdk1flox/flox; Cd4-Cre
littermates showed rectal prolapse (Figure 3A). Treatment of
the mice with Sulfatrim also abrogated colitis (Figure 3A), sug-
gesting that the response of TCRgd+ T cells to commensalmmunity 33, 791–803, November 24, 2010 ª2010 Elsevier Inc. 793
Figure 2. TCRgd+ T Cells Are Dramatically Increased in PDK1-Deficient Mice
(A) Flow cytometry of IELs and lamina propria (LP) from colon.
(B) Flow cytometry of IELs from colon.
(C) Cytometry for analysis of CD69 expression on TCRgd+ T cells in the colon IELs or in the colon LP.
(D) Flow cytometry for analysis of IFN-g- and IL-17A-expressing TCRgd+ T cells in the lymph node after stimulation with phorbol 12-myristate 13-acetate (PMA)
and ionomycin.
(E) Flow cytometry for analysis of IL-17A-expressing TCRgd+ T cells in the colon IELs after stimulation with PMA and ionomycin.
(F) Flow cytometry analysis for Vg4-expressing TCRgd+ T cells in the colon IELs.
Numbers adjacent to outlined areas indicate percent cells in each.
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TCRgd+ T cells.
PDK1 Affects Treg Cell Development
The results presented above indicated that intestinal TCRgd+
T cells, activated by commensal flora, mediate spontaneous
colitis in Pdk1flox/flox; Cd4-Cre mice. This raises the question of
how the dysregulated expansion of the TCRgd+ T cells is pre-
vented in wild-type mice. Because Treg cells play a key role in794 Immunity 33, 791–803, November 24, 2010 ª2010 Elsevier Inc.maintenance of immune homeostasis, we wanted to test the
possibility that intestinal TCRgd+ T cells are normally suppressed
by Treg cells. Therefore, we hypothesized that as in conventional
T cells, PDK1 is also necessary for Treg cell function. Because
Cd4-Cre deletes Pdk1 in CD4+CD25+Foxp3+ Treg cells, failure
of PDK1-deficient Treg cells to regulate intestinal TCRgd+
T cells could lead to colitis. We therefore examined the Treg
cell population in Pdk1flox/flox; Cd4-Cre mice. In the colon of
Pdk1flox/flox; Cd4-Cre mice compared to wild-type control
Figure 3. TCRgd+ T Cells Are Responsible
for the Development of Spontaneous Colitis
(A) Incidence of rectal prolapse (n = 7–10 mice per
group).
(B and C) Photograph (B) and histological grade
(C) of colon from each genotype (original magnifi-
cation 1003).
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Regulation of TCRgd T Cells by T Regulatory Cellsmice, the Treg cell population, as a percentage of the total Thy1+
T cell population, is decreased (Figure 4A). However, because
the total Thy1+ T cell numbers is increased in Pdk1flox/flox;Figure 4. PDK1 Significantly Affects the Treg Cell Development
(A) Flow cytometry analysis of Treg cells in the IELs from colon and gating on Thy1+ cells.
(B) Flow cytometry analysis of Thy1+ cells in the IELs from colon.
(C) Flow cytometry analysis of Treg cells from thymus and peripheral lymph nodes and gating on CD4+ cells
(D) The number of Treg cells in thymus and lymph node (n = 5 mice). Open bars, flox/flox; filled bars, +/flox.
Numbers adjacent to outlined areas indicate percent cells in each (AC).
Immunity 33, 791–803, NCd4-Cre mice (Figure 4B), the absolute
number of Treg cells was not significantly
changed. In the thymus and peripheral
lymph nodes of Pdk1flox/flox; Cd4-Cre
mice, both the percentage and absolute
number of Treg cells were reduced (Fig-
ures 4C and 4D), but this reduction was
less than that seen in Cd28/ mice (Tai
et al., 2005). This was consistent with
our finding that although PDK1 is impor-
tant for CD28 signaling to NF-kB, it
probably does not abolish all other
CD28-initiated pathways (Park et al.,
2009). Therefore our data indicate that
PDK1 only moderately affected Treg cell
development.
PDK1 Is Essential for Treg Cell
Activation and Function
Treg cells produce cytokines including
IL-10, TGF-b, and IL-35 (heterodimer of
IL-12p35 and Ebi3) during the modulationof immune responses (Shevach, 2009). Therefore, we analyzed
the ability of Pdk1flox/flox; Cd4-Cre Treg cells to produce
these cytokines upon stimulation with anti-CD3 and anti-CD28..
ovember 24, 2010 ª2010 Elsevier Inc. 795
Figure 5. PDK1 Is Necessary for the Inhibitory Function of Treg Cells
(A–C) Relative mRNA amounts of IL-10 (A), TGF-b (B), and Ebi3 (C) in Treg cells after activation with anti-CD3 and anti-CD28.
(D) ELISA analysis of IL-10 production by WT Treg cells after stimulation with either anti-CD3, anti-CD28, or anti-CD3 and anti-CD28.
(E) ELISA analysis of IL-10 production by Treg cells after stimulation with anti-CD3 and anti-CD28 with or without IL-2. Open bars, flox/flox; filled bars, +/flox.
(F) Flow cytometry analysis of intracellular CTLA-4, surface CTLA-4, CD103, GITR on Treg cells and of surface CTLA-4 andCD69 on Treg cells after activationwith
anti-CD3 and anti-CD28. All analyses were done after gating on CD4+CD25+Foxp3+.
(G) In vitro inhibition of CD4+ T cell proliferation with Treg cells.
(H) Relative IDO mRNA expression in the pDC by Treg cells activated with anti-CD3 and anti-CD28.
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Regulation of TCRgd T Cells by T Regulatory CellsAlthoughwild-type Treg cells increasedmRNA amounts of IL-10,
TGF-b, and Ebi3, PDK1-deficient Treg cells failed to upregulate
these cytokines (Figures 5A–5C). Interestingly, in WT Treg
cells the expression of IL-10, a key cytokine that regulates the
inhibitory activity of Treg cells (Rubtsov et al., 2008), was dramat-
ically increased upon CD28 coligation (Figure 5D), suggesting
that CD28 signaling could have an important role in this Treg
cell function. In addition, we found that compared to wild-type
Treg cells, PDK1-deficient Treg cells produced less IL-10, as
measured by both ELISA and intracellular cytokine staining
upon stimulation with anti-CD3 and anti-CD28 (Figure 5E and
Figure S4). We demonstrated above that CD28 coligation
increased IL-10 production, and we have previously reported
that PDK1 is involved in membrane proximal signaling during
CD3- and CD28-mediated T cell activation in CD4+ TCRab
T cell activation (Lee et al., 2005; Park et al., 2009). Consistent
with these findings, phorbol 12-myristate 13-acetate (PMA)
and ionomycin-mediated stimulation of Treg cells bypassed
the requirement for PDK1, inducing equivalent IL-10 produc-
tion in Pdk1flox/+; Cd4-Cre and Pdk1flox/flox; Cd4-Cre Treg cells
(Figure S4). Even though the production of IL-10 from Treg
cells is abrogated by Pdk1 deletion, the expression of most
Treg cell markers (intracellular CTLA-4 and Foxp3, surface
GITR, and surface CD103) in resting Treg cells were not sig-
nificantly affected (Figure 5F). These data are consistent with
recent reports that found that extrinsic IL-10 expression, by
macrophages, is necessary for the maintenance of Treg cell
markers including Foxp3 expression (Murai et al., 2009) whereas
Treg cell-intrinsic IL-10 is not required for Foxp3 expression
(Rubtsov et al., 2008). However, interestingly, although wild-
type Treg cells also expresses the early T cell activation marker
CD69 and CTLA-4 on the cell surface after activation with
anti-CD3 and anti-CD28, Treg cells lacking Pdk1 show sig-
nificantly reduced expression of cell surface CD69 and CTLA-4
(Figure 5F). CTLA-4 has been known to be involved in inhibition
of T cell proliferation by contact, and in upregulation of indole-
amine 2,3-dioxygenase (IDO) in plasmacytoid dendritic cell
(pDC), which is also important for immunomodulation (Puccetti
and Grohmann, 2007). Consistent with this, PDK1-deficient
Treg cells are only weakly inhibitory (Figure 5G) and mediate
weak induction of IDO in pDC (Figure 5H). Therefore these
in vitro data suggest that PDK1 is required for activation of
Treg cells.
We also tested the ability of PDK1-deleted Treg cells to
work in vivo by determining their ability to suppress experi-
mental colitis induced upon adoptive transfer of CD4+CD45RBhi
T cells into a Rag1/ mouse. Because PDK1 is necessary for
conventional T cell activation, PDK1-deficient CD4+CD45RBhi
T cells could not induce colitis, whereas wild-type CD4+
CD45RBhi T cells clearly induced colitis as measured by weight
loss and increased clinical scores (Figure 5I). Although trans-
fer of wild-type Treg cells could prevent the induced
colitis, transfer of PDK1-deficient Treg cells failed to prevent
colitis (Figure 5J). Therefore these experiments suggested(I) Clinical score and weight changes of mice after transfer of CD4+CD25CD45R
(J) Photograph of colon and histological grade of the colitis 10 weeks after the tr
Error bars (A–E, G, and H), SD of triplicate samples. *p < 0.05, **p < 0.01.
Ithat Treg cells required PDK1 for normal function both in vitro
and in vivo.TCRgd+ TCells Are Regulated by Treg-Derived Inhibitory
Cytokines
Interestingly, homeostatic proliferation of TCRgd+ T cells after
transfer into Rag1/ mice is inhibited by wild-type Treg cells,
but not by Treg cells from Pdk1flox/flox;Cd4-Cremice (Figure 6A).
Furthermore, TCRgd+ T cell expansion was dramatically
decreased after adoptive transfer of wild-type Treg cells into
Pdk1flox/flox; Cd4-Cre mice (Figure 6B, top). The IL-17-express-
ing TCRgd+ T cell population was also decreased after adoptive
transfer of WT Treg cells (Figure 6B, bottom). Therefore these
data indicated that Treg cells regulate TCRgd+ T cell proliferation
and function in the intestine and suggested that the main cause
for the spontaneous colitis was the inability of PDK1-deficient
Treg cells to suppress intestinal TCRgd+ T cells. We also
explored the possible mechanism by which Treg cells suppress
TCRgd+ T cell proliferation. Our results indicated that the
suppression was not through contact inhibition (data not shown),
but that CD4+CD25+ Treg cells could suppress expansion of
TCRgd+ T cells in vitro at Treg:TCRgd+ T cell ratios similar to
that seen for TCRab+ T cells (Figures 6C and 6D). Although it
has previously been shown that IL-10 contributes little to Treg
cell suppression of conventional CD4+ T cell proliferation
in vitro (Thornton and Shevach, 1998), the role of IL-10 in the
regulation of colitis remains controversial. Thus, although Treg
cell-intrinsic IL-10 production is not required for suppression of
colitis in the transfer model, mice in which IL-10 is deleted only
in Treg cells do, in fact, develop spontaneous colitis (Murai
et al., 2009; Rubtsov et al., 2008). Furthermore, it has previously
been shown that IL-10 efficiently suppresses TCRgd+ T cell
proliferation activated by Mycobacterium tuberculosis in vitro
(Pechhold et al., 1994). Therefore, based on the decreased
IL-10 production observed in the Pdk1flox/flox; Cd4-Cre mice,
we investigated the contribution of IL-10 to Treg cell suppression
of TCRgd+ T cell proliferation. Surprisingly, use of neutralizing
IL10 antibody significantly inhibited Treg cell-mediated suppres-
sion of TCRgd+ T cell proliferation (Figure 6C) but had a relatively
modest effect on proliferation of CD4+ TCRab+ T cell suppres-
sion (Figure 6D). Consistent with these findings, we found that
recombinant IL-10 directly inhibited TCRgd+ T cell proliferation
in vitro (Figure 6E). The residual suppression of TCRgd+ T cell
proliferation observed upon administration of neutralizing IL-10
antibody could be due to the production of other inhibitory cyto-
kines, such as IL-35 (Collison et al., 2007). We found that
recombinant IL-35 did indeed have an inhibitory effect on
TCRgd+ T cell proliferation in vitro (Figure S5). Interestingly,
CD8a+ TCRgd+ T cells are also dramatically increased in the
IEL of IL-10-deficient mice (Figure 6F), which do develop spon-
taneous colitis. Given that TCRgd T cells expand in the absence
of IL-10, loss of Treg cell suppression of TCRgd+ T cell prolifera-
tion in vitro by neutralization of IL-10, and inhibition of TCRgd cellBhi cells with or without Treg cells.
ansfer (original magnification 1003).
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Figure 6. Treg Cells Regulate Proliferation of TCRgd+ T Cells
(A) Flow cytometry for analysis of homeostatic proliferation of CFSE-labeled IEL TCRgd+ T cells in Rag1/ mice with or without Treg cells.
(B) Flow cytometry of IELs after adoptive transfer of WT Treg cells (top) and flow cytometry for analysis of IL-17-expressing TCRgd+ T cells in the IELs of
Pdk1flox/flox; Cd4-Cre mice (flox/flox) with or without adoptive transfer of WT Treg cells, after stimulation with PMA and ionomycin (bottom).
(C) Treg cell-mediated in vitro inhibition of TCRgd+ T cell proliferation activated with plate-bound anti-TCRgd with or without anti-IL-10 neutralizing antibody.
(D) Treg cell-mediated in vitro inhibition of CD4+ T cell proliferation activated by anti-CD3 and anti-CD28 with or without IL-10 neutralizing antibody.
(E) Inhibition of TCRgd+ T cell proliferation by IL-10 after activation with plate-bound anti-TCRgd.
(F) Flow cytometry for TCRgd+ T cells in the IELs of Il-10/ or Il-10+/+ mice.
Error bars (C–E), SD of triplicate samples. *p < 0.05, **p < 0.01. Numbers adjacent to outlined areas indicate percent cells in each (A, B, and F).
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tant for regulation of TCRgd+ T cell expansion in colon IEL.
Functional Treg Cell Adoptive Transfer Prevents
Spontaneous Colitis
To determine whether the spontaneous colitis observed in
Pdk1flox/flox; Cd4-Cremice was due to a defect in Treg cell func-
tion, versus an intrinsic dysregulation of TCRgd+ T cells, we
tested whether disease could be prevented by adoptive transfer
of wild-type Treg cells. Transfer of wild-type Treg cells into
Pdk1flox/flox; Cd4-Cre mice blocked both the development
of spontaneous colitis (Figure 7A) and elevation of serum IL-
12p40 (Figure 7B). The average weight of Pdk1flox/flox; Cd4-Cre
mice was less than littermate controls, and this weight difference
increased as the mice aged (Figure 7C). However, this progres-
sive weight loss was prevented upon the transfer of wild-type
Treg cells (Figure 7C). Moreover, the increase in amounts of798 Immunity 33, 791–803, November 24, 2010 ª2010 Elsevier Inc.inflammatory cytokines including IL-12p40 (Figure 7D), IL-
23p19 (Figure 7E), and IL-17A (Figure 7F) did not occur in
Pdk1flox/flox; Cd4-Cre mice receiving WT Treg cells. Therefore
the majority of the inflammation indices were reduced upon
transfer of wild-type Treg cells. Hence these studies demon-
strate that regulation of TCRgd+ T cells in the IEL by Treg cells
is important for intestinal homeostasis (Figure S6).
DISCUSSION
The regulation of intestinal inflammatory homeostasis is a
complex biological process, breakdown of which results in
human disease states including inflammatory bowel diseases
and even colon cancer. It is known that Rag1/ mice do not
display hyperinflammation against normal commensal bacteria,
which suggests that the immune system without T and B cells
is capable of regulating commensal bacteria without sequelae.
Figure 7. Treg Cells Are Essential for TCRgd+ T Cell Regulation to Prevent Spontaneous Colitis
(A) Photograph of colon and histological grade of the colitis 9 weeks after injection of WT Treg cells or PBS into Pdk1flox/flox; Cd4-Cre mice (flox/flox) (n = 712
mice per group) (original magnification 1003).
(B) ELISA analysis of serum IL-12p40 3 weeks after injection of WT Treg cells or PBS into Pdk1flox/flox; Cd4-Cre mice (flox/flox) (n = 4–5 mice per group).
(C) Relative weight changes of Pdk1flox/flox;Cd4-Cremice (flox/flox) after injection of WT Treg cells or PBS and of Pdk1+/flox;Cd4-Cremice (+/flox) (n = 7–12 mice
per group).
(D–F) Relative mRNA amounts of IL-12p40 (D), IL-23p19 (E), and IL-17A (F) in colon (n = 3–4 mice per each group). Error bars, SD of triplicate samples. *p < 0.05,
**p < 0.01.
Immunity
Regulation of TCRgd T Cells by T Regulatory CellsHowever,Rag1/mice cannotmount efficient defenses against
pathogenic bacterial infection in the intestine. This indicates the
necessity of a highly regulated system for efficient defense
against pathogenic bacterial infection, without upsetting normal
immune homeostasis.
The intestinal IEL compartment interfaces with intestinal
commensal bacteria, and the main T cell population in the IEL
are TCRgd+ T cells. TCRgd+ T cells are believed to be a fast-
acting T cell population because they can be activated without
professional APCs. TCRgd+ T cells have been shown to be crit-
ical for defense against intestinal bacteria because the Tcrd/
mouse and TCRgd+ T cell-depleted mouse are susceptible
to dissemination of pathogenic bacteria from the intestine
(Egan et al., 2005; Mixter et al., 1994). However, under normal
conditions, TCRgd+ T cells should be tolerant of commensal
bacteria.
Recognition of bacterial protein or nonprotein antigen in the
IEL compartment can lead to the activation of TCRgd+ T cells
(Hayday and Tigelaar, 2003; Nanno et al., 2007). According to
our data, most of TCRgd+ T cells in the IEL are constitutively acti-
vated, as indicated by the expression of the activation marker
CD69, whereas TCRgd+ T cells in LP are negative for the CD69
marker. Our study has demonstrated that TCRgd+ T cells can
cause the development of spontaneous colitis and interestingly,
Pdk1flox/flox; Cd4-Cre mice have more activated TCRgd+ T cells
in the IEL compartment, whereas the majority of the TCRgd+IT cells in the LP compartment still remain negative for the
expression of CD69. Moreover, the TCRgd+ T cell population in
the LP compartment is not increased in colitic mice, but the
TCRgd+ T cell population in the IEL compartment is. Finally,
antibiotic treatment abrogates this increase in TCRgd+ T cells
in the IEL compartment in mice in which the Pdk1 gene is
deleted. Thus TCRgd+ T cells are activated and expanded in
the IEL compartment because of recognition of commensal
bacteria, and Pdk1flox/flox; Cd4-Cremice cannot control the acti-
vation and expansion of these TCRgd+ T cells.
IL-17 is increased in the colitic area and this may contribute to
the development of colitis (Fujino et al., 2003; Yen et al., 2006).
For TCRgd+ T cells, it is known that IL-17A is mainly produced
by the Vg4 subset of TCRgd+ T cells (Martin et al., 2009). Consis-
tent with this, we find expansion of the Vg4 TCRgd+ T cell popu-
lation and enrichment of this population among the IL-17A-
expressing TCRgd+ T cell population and among the IEL TCRgd+
T cell population as a whole. These data indicate that abnormal
expansion of a potential proinflammatory TCRgd+ T cell variant
may contribute to the disease development such as colitis.
IL-17 has a complex role in colitis (O’Connor et al., 2010).
Although it has recently been reported that IL-17 has a protective
role in the adoptive transfer model of experimental colitis that is
mediated by CD4+ T cells (O’Connor et al., 2009), IL-17 is an
important mediator of spontaneous colitis in Il-10 gene-deficient
mice (Yen et al., 2006). Thus, IL-17 production by TCRgd T cellsmmunity 33, 791–803, November 24, 2010 ª2010 Elsevier Inc. 799
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Regulation of TCRgd T Cells by T Regulatory Cellsin Pdk1flox/flox;Cd4-Cre mice may contribute to the development
of intestinal inflammation in these mice.
PDK1 is regulated by the PI3K signaling pathway and activa-
tion of this signaling cascade triggers activation of several tran-
scription factors including NF-kB, NFATc, and AKT (Mora et al.,
2004; Nirula et al., 2006; Park et al., 2009). The effect of deleting
the Pdk1 gene in Treg cells is similar to the effect of mutating or
deleting PI3K in mice (Fruman and Bismuth, 2009; Oak et al.,
2006; Patton et al., 2006). We found that Treg cells do not effi-
ciently produce IL-10 without activation and that CD28 ligation
dramatically increased IL-10 production from activated Treg
cells. PDK1-deficient Treg cells also failed to induce IL-10 in
response to CD3 and CD28 ligation, but could induce IL-10
when triggered with PMA and ionomycin, which acts down-
stream of PDK1. In addition, expression of other cytokine genes
such as TGF-b and Ebi3 (subunit of IL-35) was impaired by Pdk1
gene deletion in Treg cells. Thus, PDK1 is involved in Treg cell
activation, particularly with regard to cytokine production.
Because TCRgd+ T cells recognize antigen without APCs
(Hayday and Tigelaar, 2003; Nanno et al., 2007), TCRgd+ T cell
may not recognize the same antigens as Treg cells. Previous
reports have shown that intestinal dendritic cells take up bacte-
rial antigen and present these antigens to Treg cells for their
expansion and activation (Smits et al., 2005; Strauch et al.,
2005). Therefore, the production of inhibitory cytokines such as
IL-10 by activated Treg cells may help regulate TCRgd+ T cells.
Treg cell-specific Il-10 gene deletion leads to development of
colitis (Rubtsov et al., 2008), so it is possible that Treg cell-medi-
ated production of IL-10 may be crucial to suppression of
TCRgd+ T cells. Indeed, we found that Treg cell IL-10 was neces-
sary for suppressing TCRgd+ T cell proliferation in vitro and that
in the absence of IL-10, TCRgd+ T cells underwent significant
expansion in vivo. Thus these data may help explain the unclear
role of IL-10 in colitis. In the transfer model of colitis, mediated by
TCRab+ T cells, Treg cell production of IL-10 has little bearing on
disease. However, loss of Treg cell IL-10, which leads to devel-
opment of colitis without the massive lymphoproliferation char-
acteristic of Treg cell-deficient animals, probably affects the
ability of Treg cells to suppress TCRgd+ T cell proliferation.
Therefore, whereas Treg cell-extrinsic IL-10 production is neces-
sary for maintenance of Treg cell-encoded FOXP3 expression
and IL-10-independent suppression of CD4+ T cells in the trans-
fer model of colitis (Murai et al., 2009), Treg cell-produced IL-10
probably is crucial to suppression of TCRgd+ T cells and preven-
tion of spontaneous colitis in the Pdk1flox/flox; Cd4-Cre mouse.
In summary, even though conventional TCRab+ T cells cannot
be activated in Cd4-Cre-mediated PDK1-deleted mice, these
mice developed spontaneous colitis. The spontaneous colitis
was prevented by deletion of the Tcrd gene, demonstrating the
active role of TCRgd+ T cells in this process. Moreover, transfer
of WT Treg cells blocked spontaneous colitis and inhibited
TCRgd+ T cell expansion in the colonic intraepithelial compart-
ment of these mice. Furthermore, colitis was prevented by treat-
ment with antibiotics, suggesting that TCRgd+ T cells are contin-
uously activated by commensal bacteria and can induce
spontaneous colitis if the TCRgd+ T cells are not regulated by
Treg cells. Our in vitro data demonstrate that Treg cells can
suppress TCRgd+ T cell proliferation through IL-10 and that
PDK1-deleted Treg cells are deficient in IL-10 production. Our800 Immunity 33, 791–803, November 24, 2010 ª2010 Elsevier Inc.in vivo experimental model shows that functional Treg cells are
important for suppressing TCRgd+ T cell responses against
commensal bacteria. Thus, suppression of TCRgd+ T cells by
Treg cells occurs in vivo and is important for maintaining normal
intestinal homeostasis.EXPERIMENTAL PROCEDURES
Mice
Pdk1flox/flox mice (Hashimoto et al., 2006) were first bred with Cd4-Cre trans-
genic mice (Lee et al., 2001) and offspring were bred with Pdk1flox/flox mice
to generate Pdk1flox/flox; Cd4-Cre and Pdk1+/flox; Cd4-Cre. For making of
PDK1 and TCRd double-deficient mice, Pdk1flox/flox; Cd4-Cre mice were
bred with TCRd-deficient (Tcrd/) mice. All mice were kept in specific path-
ogen-free conditions in the animal care facility at Columbia University (New
York, NY) or Yale University (New Haven, CT). All mouse experiments were
approved by Institutional Animal Care andUseCommittee of Columbia Univer-
sity and Yale University.Antibodies and Reagents
Fluorescein isothiocyanate-conjugated anti-mouse TCRb (H57-597), allophy-
cocyanin-conjugated anti-mouse CD19 (1D3), phycoerythrin-conjugated
anti-mouse CD4 (GK1.5), allophycocyanin-conjugated anti-mouse CD8a
(53-6.7), fluorescein isothiocyanate-conjugated anti-mouse CD8a (53-6.7), al-
lophycocyanin-conjugated anti-mouse CD8a (53-6.7), fluorescein isothiocya-
nate-conjugated anti-mouse TCRgd (UC7-13D5), allophycocyanin-conju-
gated anti-mouse IL-17 (eBio17B7), phycoerythrin-conjugated anti-mouse
thy1 (53-2.1), peridinin chlorophyll protein-conjugated anti-mouse CD33
(17A2), peridinin chlorophyll protein-Cy5.5-conjugated anti-mouse CD25
(PC61.5), and Alexa 647-conjugated anti-mouse Foxp3 (FJK-16 s) were
purchased from eBioscience. IL-10 was purchased from eBioscience. IL-35
(IL-35 2A and IL-35 GS) was produced in HEK293 cells through transfection
of pIg-IL-35-2A or pIg-IL-35-GS. pIg-NEO was used for the control.Flow Cytometry and ELISA Analysis
Cells were isolated from the thymi, lymph nodes, and intestine of Pdk1+/flox;
Cd4-Cre or Pdk1flox/flox; Cd4-Cre mice. The cells were stained with indicated
antibodies and analyzed on a FACSCalibur instrument. Live cells were gated
for analysis. Intracellular Foxp3 was stained with BD Cytofix-Cytoperm Plus
and Alexa 647-conjugated anti-mouse Foxp3 antibody. Secreted-IL-10
amount was analyzed by IL-10-specific ELISA (eBioscience). In brief, 5 3
104 cells per well were plated in 96-well plates coated with either anti-mouse
CD33 (5 mg/ml), anti-mouse CD28 (5 mg/ml), or both anti-mouse CD33 (5 mg/ml)
and anti-mouse CD28 (5 mg/ml). And then, the cells were incubated at 37C
and 5% CO2. 48 hr later, the culture medium was analyzed.Colon Organ Culture
In brief, 1 cm3 1 cm standardized segments of all three parts of the colonwere
washed in cold PBS supplemented with penicillin and streptomycin (Invitro-
gen). These segments were cultured in 24-well flat-bottom culture plates
(Falcon) in serum-free RPMI 1640 medium (Invitrogen) supplemented with
penicillin and streptomycin. After 24 hr, supernatant fluid was collected and
was used for estimation of IL-12p40 secretion.Isolation of RNA and Quantitative Reverse-Transcriptase PCR
For quantitative RT-PCR, tissue was chopped and homogenized with a sterile
syringe piston in TRIZOL (Invitrogen), and total RNA was isolated according to
manufacturer’s instructions. DNA was digested with DNase I and the DNaseI
was heat inactivated. RNA was reverse transcribed by Superscript II (Invitro-
gen), and cDNAs were used for PCR with Quantitect SYBR Green reagents
(QIAGEN, Valencia, CA) on a Stratagene MX3000 bioanalyzer (La Jolla, CA).
The abundance of each cytokine mRNA was normalized to b-actin expression
and compared to the samemRNAs inWT intestines to calculate the fold induc-
tion. Sequences of primers available upon request.
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IELs were prepared as previously reported (Weigmann et al., 2007) with slight
modification. In brief, intestine was washed with ice-cold PBS and cut into the
small pieces that were incubated with IEL preparation buffer containing 1 3
HBSS containing 5% FBS, 1 mM DTT, and 5 mM EDTA at 37C shaking incu-
bator for 20 min twice. The supernants were collected and filtered by 40 mM
cell strainer. Cells were washed with 13HBSS three times. For flow cytometry
analysis, lymphocytes were gated.
Functional Assessment of Treg Cells In Vivo
CD4+CD25CD45RBhi or CD4+CD25+CD45RBlo T cells were isolated from
Pdk1+/flox; Cd4-Cre or Pdk1flox/flox; Cd4-Cre via a MoFlow (Dako) or
FACSAria instrument (BD Biosciences) on the basis of the staining. At day 0,
Rag1-deficient (Rag1/) mice were injected intravenously with 4 3 105
CD4+CD25CD45RBhi T cells alone or in combination with 1 3 105
CD4+CD25+CD45RBlo T cells. Clinical scores were monitored every week for
signs of colitis. The clinical score was defined as follows. Wasting: 0, no
wasting; 1, 0.1%–10% loss of initial total body weight; 2, >10% loss of initial
total body weight. Diarrhea: 0, none; 1, soft stool; 2, watery and/or bloody.
Hunching, bristled fur, and skin lesions: 0, unchanged; 1, any positive sign.
Rectum prolapse: 0, absent; 1, present. 8–12 weeks after transfer, mice
were killed and colons were dissected, fixed in 4% buffered formalin, and
embedded in paraffin for histological analysis.
In Vitro Suppression Assays
5 3 104 CD4+CD25 cells were cultured in 96-well plates with 105 irradiated
T cell-depleted splenocytes and 0.5 mg/ml anti-CD33 (BD Biosciences).
CD4+CD25+CD45RBlo cells from lymph nodes of Pdk1+/flox; Cd4-Cre or
Pdk1flox/flox; Cd4-Cre mice were added to the culture in various ratios as indi-
cated. The T cell proliferation was analyzed by pulsing the cells for 12 hr with
1 mCi [3H]thymidine after 60 hr of stimulation. For suppression of TCRgd+
T cells, Treg cells were preactivated with anti-CD3 and anti-CD28.
Histology and Scoring
The specimens were fixed with 4% neutral-buffered formalin and embedded in
paraffin. Sections were cut, deparaffinized, and stained with hematoxylin and
eosin. The stained intestinal sections were graded by a blinded scorer. Histo-
logical grading was based on observed inflammation (0–4) and observed
epithelial injury (0–4). Clinical scores of observed inflammation were defined
as follows: 0, no increase inflammation; 1, low level of inflammation with mildly
increased inflammatory cells in the lamina propria; 2, moderately increased
inflammation in the lamina propria (multiple foci); 3, high level of inflammation
with evidence of wall thickening by inflammation; 4, maximal severity of inflam-
mation with transmural leukocyte infiltration and/or architectural distortion.
Grading scores of observed epithelial injury was defined as follows: 0, normal
or no inflammation by neutrophils; 1, occasional epithelial lesion (focal and
superficial or rare cryptitis); 2, foci of cryptitis, including rare crypt abscess;
3, multiple crypt abscess and/or focal ulceration; 4, grade 3 + extensive
ulceration.
Intracellular IL-17 Staining and Flow Cytometry
For intracellular IL-17 staining, freshly isolated IELs were cultured for 5 hr in
complete media (RPMi1640 containing 5% FBS) supplemented with 50 ng/
ml PMA, 500 ng/ml ionomycin, and 1 ml/ml BD GolgiPlug (BD PharMingen) in
96-well plates. Cell were harvested and processed with the Intracellular
Cytokine Staining kit (BD PharMingen). Cells were stained with anti-TCRgd
and anti-IL-17. The stained cells were analyzed by FACSCalibur flow cytome-
ters (Becton-Dickenson).
Homeostatic Proliferation of TCRgd+ T Cell in Intestinal
Intraepithelial Cell
TCRgd+ T cells were isolated from lymph nodes of Pdk1flox/flox; Cd4-Cre mice
via a MoFlow (Dako) or FACSAria (BD Biosciences) instrument on the basis of
the staining. The isolated TCRgd+ T cells were stained with 5 mM of CFSE for
5 min and then the labeling was stopped by addition of FBS. After wash with
PBS, the cells were injected into Rag1/mice and 5 days later from the injec-
tion, IELs were prepared from the mice and the proliferation was analyzed by
flow cytometry.IAdoptive Transfer of WT Treg Cells to Rescue the Spontaneous
Colitis
WT Treg cells (CD4+CD25+CD45RBlo) were isolated from lymph nodes of
Pdk1+/flox; Cd4-Cremice with a MoFlow (Dako) or FACSAria (BD Biosciences)
instrument on the basis of the staining. Pdk1flox/flox; Cd4-Cre mice (10- to
12-week-old mice) were injected intravenously three times with the isolated
WT Treg cells (1 3 105 per mouse) every 3 weeks. After 3 weeks from the
last injection of Treg cells, colon tissue samples were collected for histological
analysis and mRNA expression analysis.
Statistical Analyses
All statistical analyses were performed with the two-tailed Student’s t test with
unequal variance.SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and can be found with this
article online at doi:10.1016/j.immuni.2010.10.014.
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